Westover Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Westover Capital Advisors's LLY Position: Q1 2026 in Review
Westover Capital Advisors increased its Eli Lilly (LLY) stake by 77% in Q1 2026, buying an estimated $1.61M and bringing the position to 3,656 shares worth $3.36M. The position accounts for 0.62% of the portfolio, ranked #40.
Westover Capital Advisors first reported a position in LLY in Q1 2019 and has held it in 27 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Westover Capital Advisors held 3,656 shares of Eli Lilly worth $3.36M as of Q1 2026.
- Westover Capital Advisors bought 1,585 Eli Lilly shares in Q1 2026, an estimated $1.61M.
- Eli Lilly made up 0.62% of Westover Capital Advisors's portfolio in Q1 2026, its #40 holding.
- Westover Capital Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 27 quarters since.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Westover Capital Advisors's 13F filing for Q1 2026, filed 5 May 2026.